SGRY
Surgery Partners Inc
14.20$
-2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8% | 17.2% | 5.4% | 8.8% | 10.9% | 9.0% | 8.2% | 7.1% | 13.3% | 3.9% | 6.3% | 10.7% | 9.6% | 8.3% | |
| 4.3% | 4.1% | 3.7% | 3.6% | 3.5% | 3.9% | 3.8% | 4.2% | 5.1% | 4.4% | 4.5% | 4.3% | 4.9% | 5.3% | |
| 0.2% | 0.2% | 0.2% | 0.8% | 0.2% | 0.4% | 0.5% | 0.6% | 0.7% | 0.8% | 0.7% | 0.6% | 1.1% | 0.4% | |
| – | – | 22.0% | 9.1% | 10.4% | 4.6% | 6.2% | 2.1% | 1.4% | 1.6% | 1.8% | – | – | – | |
| -2.0% | -3.5% | -4.9% | -4.6% | -3.8% | 6.3% | 1.9% | -3.8% | -3.0% | -6.7% | -4.0% | -2.3% | -3.8% | -3.3% | |
| 1.8% | 1.5% | 2.3% | 3.5% | 3.4% | 2.2% | 2.2% | 4.0% | 2.3% | 2.6% | 3.2% | 3.2% | 2.9% | 2.4% | |
| -1.3% | -1.3% | -67.2% | -14.0% | -16.1% | -58.4% | -7.3% | -4.7% | -4.8% | -14.9% | -12.1% | -8.2% | -15.7% | -7.5% | |
| – | 46.0% | 23.1% | 0.1% | 7.5% | 0.1% | 0.4% | 6.6% | 5.9% | 0.2% | 5.8% | 0.0% | – | – | |
| – | – | -0.8% | 26.1% | 0.0% | -0.1% | -0.1% | -0.2% | -1.5% | -10.5% | 33.6% | – | – | – | |
| – | – | 115.9% | -13.4% | 15.4% | 46.5% | 6.9% | 0.4% | 11.0% | -2.5% | -25.4% | 0.7% | 14.5% | 4.9% | |
| -16.5% | -13.2% | 77.1% | 3.5% | 6.2% | 57.2% | -0.4% | -7.4% | 3.6% | 14.2% | 1.7% | -5.7% | 8.4% | -1.7% | |
| -0.1% | 2.7% | 15.3% | -1.8% | 1.0% | 0.9% | 0.5% | -5.0% | 12.1% | 3.2% | -4.2% | -3.2% | 2.4% | -0.9% | |
| 16.0% | 15.8% | 3.1% | 5.3% | 7.5% | 6.8% | 5.9% | 3.1% | 11.0% | 1.3% | 3.1% | 7.5% | 6.7% | 5.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.